PeptidePrices safety rating
5/10 · Not FDA-approved (trials halted)
8 vendors · 3 with an issuer-verified COA · lowest 10mg from $535.10 · checked
| Vendor | Price | Actions |
|---|---|---|
| $535.1010 × 1mg packages · 10mg totalChecked today | Buy ACE-031 from Kensington Labs | |
| 3-test panelVerified COAMZ BioLabs · Tested Dec 22, 2025 | $540.00 | Buy ACE-031 from Novaglo Research |
| $801.8010 × 1mg packages · 10mg totalChecked today | Buy ACE-031 from Pure Peptides UK | |
| $874.80 | Buy ACE-031 from Pantheon Peptides | |
| 2-test panelVerified COAOptima Labs | $1069.7010 × 1mg packages · 10mg totalChecked Sep 20 | Buy ACE-031 from Peptides Lab UK |
| $1350.00 | Buy ACE-031 from Nationwide Peptides | |
| 6-test panelVerified COABioSyn Systems · Tested Dec 3, 2025 | $1439.92 | Buy ACE-031 from Cenexa Labs |
| $1750.0010 × 1mg packages · 10mg totalChecked today | Buy ACE-031 from Alpha Carbon Labs |
Tracked every day
The five cheapest in-stock package prices for ACE-031 on each collected day, and the vendors that most often held those places.
Five cheapest in-stock package prices per day
Listed package price before coupons, any vial size. This is not the coupon-adjusted lowest 10mg price used to rank the comparison.
Vendors most often in the cheapest five
Current market data
A current summary of public listings after the price comparison above. Shipping and tax are not included.
The lowest current 10mg cost for ACE-031 is $535.10 from Kensington Labs. The median across vendors is $972.25.
PeptidePrices found 8 in-stock listings from 8 vendors, checked through Oct 10, 2026. The lowest 10mg cost is 45% below the vendor median of $972.25; 4 vendors (50%) fall below that median. 8 of 8 vendors (100%) publish public COA evidence.
A public COA link shows that a vendor publishes testing data. It does not prove that every listed vial has a matching current report. Match the product, strength, batch, and lot before relying on a report.
The headline and median use each vendor's lowest whole-package checkout cost to obtain at least 10mg. Smaller packages are multiplied until the target is met, while larger packages retain their full checkout price. The lowest package total is shown only as secondary context because package sizes differ. Known public coupon discounts are applied. Shipping, tax, and unverified promotions are excluded.
Research context
5/10 · Not FDA-approved (trials halted)
Fusion protein of activin receptor IIB and Fc; sequesters myostatin, activin A/B, GDF-8/11, and BMP9; broad inhibition of TGF-β superfamily ligands that suppress muscle growth.
Muscle wasting diseases (Duchenne MD, spinal muscular atrophy); extreme muscle growth; research compound for myostatin inhibition.
Research / preclinical only
~12-14 days.
Lyophilized vial: store at -20°C long-term or 2-8°C short-term, protected from light.
Nosebleeds, gum bleeding, telangiectasias, spider veins (vasculature effects); muscle cramping; trials halted due to these effects. Significant risk profile.
Trials paused due to minor vascular effects (nosebleeds, telangiectasias); generally tolerated at lower doses Safety ratings summarize published clinical data, adverse-event reporting, and regulatory status. How PeptidePrices rates evidence. Research information only, not medical advice.
Related pages